Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23

Molecular Immunology

Volumn 44, Issue 9, 2007, Pages 2388-2399

  Debnath, Irina ^a   Roundy, Kirstin M ^a   Weis, Janis J ^a   Weis, John H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

B cells; BAFF; Complement receptor; Transcription

Indexed keywords

CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN; PROTEIN BAFF; PROTEIN P52; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL COUNT; CELL MATURATION; CELL POPULATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SPLEEN; WILD TYPE;

AGING; ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B P52 SUBUNIT; PROTEIN BINDING; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPLEEN;

MUS;

EID: 33846191180     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.10.019     Document Type: Article

References (45)

1. Allman D., Lindsley R.C., DeMuth W., Rudd K., Shinton S.A., and Hardy R.R. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167 (2001) 6834-6840
2. Amanna I.J., Dingwall J.P., and Hayes C.E. Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice. J. Immunol. 170 (2003) 4593-4600
3. Cancro M.P. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation. Immunol. Rev. 202 (2004) 237-249
4. Cao M., Chen L., Shan X.X., and Zhang S.Q. Immunological effects of refolded human soluble BAFF synthesized in Escherichia coli on murine B lymphocytes in vitro and in vivo. Jpn. J. Physiol. 55 (2005) 221-227
5. Chang H., Gwack Y., Kingston D., Souvlis J., Liang X., Means R.E., Cesarman E., Hutt-Fletcher L., and Jung J.U. Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA. J. Virol. 79 (2005) 4651-4663
6. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3 (2002) 958-965
7. Craxton A., Draves K.E., Gruppi A., and Clark E.A. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J. Exp. Med. 202 (2005) 1363-1374
8. Day E.S., Cachero T.G., Qian F., Sun Y., Wen D., Pelletier M., Hsu Y.M., and Whitty A. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 44 (2005) 1919-1931
9. Dedon P.C., Soults J.A., Allis C.D., and Gorovsky M.A. A simplified formaldehyde fixation and immunoprecipitation technique for studying protein-DNA interactions. Anal. Biochem. 197 (1991) 83-90
10. Do R.K., Hatada E., Lee H., Tourigny M.R., Hilbert D., and Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192 (2000) 953-964
11. Fourie A.M., Coles F., Moreno V., and Karlsson L. Catalytic activity of ADAM8, ADAM15 and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 278 (2003) 30469-30477
12. Gorelik L., Cutler A.H., Thill G., Miklasz S.D., Shea D.E., Ambrose C., Bixler S.A., Su L., Scott M.L., and Kalled S.L. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J. Immunol. 172 (2004) 762-766
13. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
14. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., Rixon M., Schou O., Foley K.P., Haugen H., McMillen S., Waggie K., Schreckhise R.W., Shoemaker K., Vu T., Moore M., Grossman A., and Clegg C.H. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease impaired B cell maturation in mice lacking BLyS. Immunity 15 (2001) 289-302
15. Harada N., Santos-Argumedo L., Chang R., Grimaldi J.C., Lund F.E., Brannan C.I., Copeland N.G., Jenkins N.A., Heath A.W., Parkhouse R.M., et al. Expression cloning of a cDNA encoding a novel murine B cell activation marker. Homology to human CD38. J. Immunol. 151 (1993) 3111-3118
16. Harless S.M., Lentz V.M., Sah A.P., Hsu B.L., Clise-Dwyer K., Hilbert D.M., Hayes C.E., and Cancro M.P. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr. Biol. 11 (2001) 1986-1989
17. Hatada E.N., Do R.K., Orlofsky A., Liou H.C., Prystowsky M., MacLennan I.C., Caamano J., and Chen-Kiang S. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J. Immunol. 171 (2003) 761-768
18. Hu H., Martin B.K., Weis J.J., and Weis J.H. Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J. Immunol. 158 (1997) 4758-4768
19. Hymowitz S.G., Patel D.R., Wallweber H.J., Runyon S., Yan M., Yin J., Shriver S.K., Gordon N.C., Pan B., Skelton N.J., Kelley R.F., and Starovasnik M.A. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J. Biol. Chem. 280 (2005) 7218-7227
20. Ishihara K., Kobune Y., Okuyama Y., Itoh M., Lee B.O., Muraoka O., and Hirano T. Stage-specific expression of mouse BST-1/BP-3 on the early B and T cell progenitors prior to gene rearrangement of antigen receptor. Int. Immunol. 8 (1996) 1395-1404
21. Johnson T.A., Wilson H.L., and Roesler W.J. Improvement of the chromatin immunoprecipitation (ChIP) assay by DNA fragment size fractionation. Biotechniques 31 (2001) 740-742
22. Kalled S.L., Ambrose C., and Hsu Y.M. The biochemistry and biology of BAFF, APRIL and their receptors. Curr. Dir. Autoimmun. 8 (2005) 206-242
23. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., Grewal I.S., Cochran A.G., Gordon N.C., Yin J., Starovasnik M.A., and Dixit V.M. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17 (2002) 515-524
24. Lentz V.M., Cancro M.P., Nashold F.E., and Hayes C.E. Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J. Immunol. 157 (1996) 598-606
25. Lentz V.M., Hayes C.E., and Cancro M.P. Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J. Immunol. 160 (1998) 3743-3747
26. Loder F., Mutschler B., Ray R.J., Paige C.J., Sideras P., Torres R., Lamers M.C., and Carsetti R. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190 (1999) 75-89
27. Mackay F., Schneider P., Rennert P., and Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21 (2003) 231-264
28. Miller D.J., and Hayes C.E. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur. J. Immunol. 21 (1991) 1123-1130
29. Miller J.P., Stadanlick J.E., and Cancro M.P. Space, selection and surveillance: setting boundaries with BLyS. J. Immunol. 176 (2006) 6405-6410
30. Morrison M.D., Reiley W., Zhang M., and Sun S.C. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. J. Biol. Chem. 280 (2005) 10018-10024
31. Ng L.G., Ng C.H., Woehl B., Sutherland A.P., Huo J., Xu S., Mackay F., and Lam K.P. BAFF costimulation of Toll-like receptor-activatedB-1 cells. Eur. J. Immunol. 36 (2006) 1837-1846
32. Ni C.Z., Oganesyan G., Welsh K., Zhu X., Reed J.C., Satterthwait A.C., Cheng G., and Ely K.R. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J. Immunol. 173 (2004) 7394-7400
33. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., Lin L.L., Mantchev G.T., Bram R.J., and Noelle R.J. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199 (2004) 91-98
34. Reimold A.M., Iwakoshi N.N., Manis J., Vallabhajosyula P., Szomolanyi-Tsuda E., Gravallese E.M., Friend D., Grusby M.J., Alt F., and Glimcher L.H. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412 (2001) 300-307
35. Sasaki Y., Casola S., Kutok J.L., Rajewsky K., and Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J. Immunol. 173 (2004) 2245-2252
36. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., Frew E., and Scott M.L. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293 (2001) 2111-2114
37. Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17 (2005) 282-289
38. Shaffer A.L., Shapiro-Shelef M., Iwakoshi N.N., Lee A.H., Qian S.B., Zhao H., Yu X., Yang L., Tan B.K., Rosenwald A., Hurt E.M., Petroulakis E., Sonenberg N., Yewdell J.W., Calame K., Glimcher L.H., and Staudt L.M. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles and increases protein synthesis in plasma cell differentiation. Immunity 21 (2004) 81-93
39. Srivastava B., Quinn III W.J., Hazard K., Erikson J., and Allman D. Characterization of marginal zone B cell precursors. J. Exp. Med. 202 (2005) 1225-1234
40. Tan S.S., and Weis J.H. Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times. Genome Res. 2 (1992) 137-143
41. Tan S.M., Xu D., Roschke V., Perry J.W., Arkfeld D.G., Ehresmann G.R., Migone T.S., Hilbert D.M., and Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 48 (2003) 982-992
42. Weinmann A.S., and Farnham P.J. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26 (2002) 37-47
43. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., Cancro M., Grewal I.S., and Dixit V.M. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11 (2001) 1547-1552
44. Zabel M.D., and Weis J.H. Cell-specific regulation of the CD21 gene. Int. Immunopharmacol. 1 (2001) 483-493
45. Zhang X., Park C.S., Yoon S.O., Li L., Hsu Y.M., Ambrose C., and Choi Y.S. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int. Immunol. 17 (2005) 779-788